The global Blood Collection Market was valued at USD 5.0 billion in 2025 and is projected to grow from USD 5.3 billion in 2026 to USD 8.2 billion by 2033, registering a CAGR of 6.3% from 2026 to 2033. The market continues to expand due to the rising volume of diagnostic procedures, increasing prevalence of chronic and infectious diseases, and growing demand for accurate laboratory testing across healthcare systems worldwide.
Blood collection remains a critical component of modern healthcare, supporting disease diagnosis, treatment monitoring, preventive screening, and clinical research. As healthcare providers increasingly emphasize early disease detection and personalized treatment strategies, the demand for reliable blood collection technologies continues to grow. Hospitals, diagnostic laboratories, clinics, and blood banks are investing in advanced collection systems that improve sample integrity, patient comfort, and testing accuracy.
The growing burden of chronic diseases such as diabetes, cardiovascular disorders, cancer, and kidney diseases is creating sustained demand for routine blood testing. In parallel, the continued monitoring of infectious diseases and public health threats has reinforced the importance of efficient blood collection infrastructure in supporting timely diagnosis and disease surveillance.
Rising Diagnostic Testing Driving Market Expansion
One of the primary factors fueling blood collection market growth is the increasing number of diagnostic tests performed globally. Blood samples remain the foundation of many laboratory analyses, enabling healthcare professionals to evaluate patient health, monitor disease progression, and assess treatment effectiveness.
Key diagnostic applications include:
Disease screening and prevention
Medication monitoring
Cancer diagnostics
Cardiovascular risk assessment
Infectious disease detection
Diabetes management
Organ function evaluation
Clinical research studies
The growing focus on preventive healthcare is encouraging regular health checkups and routine blood testing, particularly among aging populations and individuals at risk of chronic conditions. This trend continues to strengthen demand for blood collection devices, tubes, needles, and related consumables.
Importance of Sample Integrity and Transportation
Maintaining blood sample quality throughout collection, storage, and transportation remains a critical challenge for healthcare providers and laboratories.
Blood samples often require strict temperature control to preserve stability and prevent degradation. Improper handling can compromise diagnostic accuracy and potentially lead to incorrect treatment decisions. For example, inadequate temperature management during transportation may affect coagulation samples, resulting in inaccurate test outcomes and unnecessary medical interventions.
As healthcare systems increasingly rely on centralized laboratory networks and remote testing facilities, demand is rising for advanced blood collection solutions that support:
Improved sample preservation
Enhanced transportation safety
Reduced contamination risks
Better traceability and tracking
Faster laboratory turnaround times
These requirements are driving innovation across blood collection technologies and logistics systems.
Key Market Trends & Insights
North America Dominates Global Market
North America accounted for 39.08% of global blood collection market revenue in 2025, making it the largest regional market.
The region benefits from:
Advanced healthcare infrastructure
High diagnostic testing volumes
Strong adoption of laboratory technologies
Growing prevalence of chronic diseases
Significant healthcare spending
Established reimbursement systems
The United States continues to lead regional growth due to increasing demand for diagnostic services, preventive healthcare initiatives, and expanding clinical laboratory networks.
Looking for more specific insights? Customize this report to suite your business needs
Venous Blood Collection Remains the Preferred Collection Site
The venous segment held 81.66% of market share in 2025.
Venous blood samples provide larger specimen volumes and support a broad range of laboratory tests.
Rising incidence of chronic diseases has increased demand for comprehensive diagnostic evaluations requiring venous samples.
Hospitals, diagnostic centers, and specialty clinics continue to rely heavily on venous collection procedures for accurate laboratory analysis.
Diagnostics Segment Leads Applications
The diagnostics segment accounted for 83.36% of market share in 2025.
Growing demand for rapid, accurate, and minimally invasive testing is supporting segment growth.
Blood-based diagnostics remain essential for identifying infections, monitoring chronic diseases, and supporting personalized treatment plans.
Increasing adoption of precision medicine and biomarker-based testing is further expanding diagnostic applications.
Manual Blood Collection Maintains Dominance
The manual blood collection segment captured 81.73% of market share in 2025.
Manual collection methods remain widely used due to their reliability, flexibility, and cost-effectiveness.
Healthcare professionals prefer manual techniques when dealing with:
Pediatric patients
Elderly individuals
Difficult vein access cases
Specialized clinical procedures
Despite growing automation in laboratory environments, manual collection continues to represent the industry standard across many healthcare settings.
Hospitals Lead End-Use Demand
The hospital segment held 39.12% of market share in 2025.
Hospitals perform a high volume of diagnostic tests, emergency procedures, surgeries, and patient monitoring activities.
Continuous patient inflow creates consistent demand for blood collection tubes, needles, lancets, and sample management systems.
Increasing hospital investments in laboratory modernization are further supporting market growth.
Market Size & Forecast
Market Size in 2025: USD 5.0 Billion
Estimated Market Size in 2026: USD 5.3 Billion
Projected Market Size by 2033: USD 8.2 Billion
CAGR (2026–2033): 6.3%
Largest Regional Market: North America
Fastest-Growing Region: Asia Pacific
Emerging Trends Reshaping the Industry
Growth of At-Home Blood Collection
A significant emerging trend is the development of patient-centric blood collection technologies that enable remote and at-home sample collection.
Healthcare providers are increasingly embracing decentralized healthcare models, telehealth services, and home-based diagnostics. This shift has created demand for minimally invasive collection devices that allow patients to collect samples outside traditional healthcare facilities.
Benefits include:
Improved patient convenience
Reduced healthcare facility visits
Enhanced accessibility for rural populations
Greater support for remote monitoring programs
Lower healthcare delivery costs
Digital Healthcare Integration
The integration of blood collection systems with digital healthcare platforms is enhancing workflow efficiency and sample tracking. Advanced technologies now support:
Barcode-enabled sample identification
Electronic health record integration
Automated specimen tracking
Improved laboratory workflow management
Enhanced data accuracy
These innovations are helping healthcare organizations reduce errors while improving patient outcomes.
Competitive Landscape
The blood collection market remains highly competitive, with established manufacturers focusing on innovation, product quality, and global expansion.
Leading companies continue investing in:
Advanced blood collection devices
Patient-friendly collection technologies
Safety-engineered products
Automated collection systems
Decentralized diagnostic solutions
Strategic partnerships and acquisitions
Emerging companies are introducing innovative solutions designed to improve patient comfort and support home-based diagnostics, creating new opportunities within the industry.
Key Blood Collection Companies
The following companies have been profiled in the global blood collection market:
Abbott
NIPRO Medical Corporation
BD
Terumo Corporation
Medtronic
QIAGEN
FL Medical s.r.l.
Greiner AG
Haemonetics Corporation
F. Hoffmann-La Roche Ltd.
Sarstedt AG & Co. KG
Centogene N.V.
SEKISUI CHEMICAL CO., LTD.
Conclusion
The global blood collection market is experiencing steady growth driven by the increasing demand for diagnostic testing, rising prevalence of chronic and infectious diseases, and expanding healthcare access worldwide. As healthcare systems place greater emphasis on early diagnosis, preventive care, and personalized medicine, blood collection technologies remain essential to supporting accurate clinical decision-making.
Emerging innovations such as at-home blood collection devices, digital sample tracking, and decentralized diagnostic solutions are transforming traditional blood collection practices and improving patient convenience. With continued investments in healthcare infrastructure, laboratory modernization, and advanced collection technologies, the blood collection market is expected to maintain strong growth momentum through 2033.
Looking for a report customized to your requirements? Explore our Custom Research Offering
Grand View Research offers
Focused market intelligence reports on specific geographies or high-growth segments
Extended forecast timelines for long-term planning
Competitor Benchmarking and Supply Chain Analysis
Inclusion of regulatory and policy assessments
Inclusion of custom data models, KPIs, or applications unique to your business
Specific high-impact Data Decks and Tables to support effective decision making
And much more…
Comments
Log in or sign up to join the conversation.